A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Clinical trial NCT05229068 · WITHDRAWN

Trial details

NCT number: NCT05229068
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2022-03-11
Primary completion: 2023-11-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.